Bharat Biotech’s Covaxin gets emergency approval for 6-12 age group Nation Bharat Biotech’s Covaxin gets emergency approval for 6-12 age group News Analysis India 2 years ago By PTI NEW DELHI: Bharat Biotech International Ltd (BBIL) on Tuesday said its COVID-19 vaccine, Covaxin, has received emergency use approval in children 6-12...Read More